
Mining protein-protein interactions for targeted cancer drug discovery
PPI Pharmaceuticals, LLC is a South Carolina drug discovery company developing cancer therapeutics that exploit protein-protein interactions.
Mission
To develop next-generation cancer therapeutics by utilizing novel technology to exploit protein-protein interactions.
Focus
Protein kinases deregulated in oncology indications — with emphasis on allosteric and non-catalytic PPI interfaces that conventional ATP-site drugs leave untouched.
